| (Values in U.S. Thousands) | Oct, 2024 | Jul, 2024 | Apr, 2024 | Jan, 2024 | Oct, 2023 |
| Sales | 33,480 | 40,170 | 42,970 | 33,820 | 25,400 |
| Sales Growth | -16.65% | -6.52% | +27.06% | +33.15% | -32.68% |
| Net Income | -17,410 | -5,530 | -123,150 | -6,010 | -9,510 |
| Net Income Growth | -214.83% | +95.51% | -1,949.08% | +36.80% | -355.02% |
Avid Bioservices Inc (CDMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It also offer process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. Avid Bioservices Inc., formerly known as Peregrine Pharmaceuticals Inc., is based in TUSTIN, United States.
Fiscal Year End Date: 04/30